AnalystsPatrick DolezalPatrick Dolezal's Stock Forecasts
AnalystsPatrick Dolezal
Sectors:
Analyst Ranking
Top 32%
#1751 out of 5550 analysts
Average Return
+101.39%
Win Rate
100%5 out of 5
Risk vs Reward
Poor
Good
Patrick Dolezal's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Kodiak Sciences IncKOD | +401.34% | $17.11 | $85.78 | 2025-10-23 - 2026-10-22 | Buy |
Neurogene IncNGNE | +44.09% | $19.12 | $27.55 | 2026-01-26 - 2026-10-30 | Buy |
Avadel Pharmaceuticals PLCAVDL | +37.36% | $13.33 | $18.31 | 2023-05-02 - 2024-05-01 | Buy |
Entera Bio LtdENTX | +13.88% | $2.81 | $3.20 | 2026-09-23 - 2026-10-30 | Buy |
Kodiak Sciences IncKOD | +10.30% | $89.92 | $99.18 | 2026-09-28 - 2026-10-30 | Buy |
Patrick Dolezal Analyst Color
Get additional color on Patrick Dolezal's coverage of popular stocks
Patrick Dolezal's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kodiak Sciences IncKOD | 2 | Buy | $145.00 | +46.20% | Maintains | a month ago |
Entera Bio LtdENTX | 1 | Buy | $10.00 | +212.50% | Initiates Coverage On | a month ago |
Neurogene IncNGNE | 1 | Buy | $50.00 | +81.49% | Initiates Coverage On | 9 months ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Buy | $26.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.